Australia's largest stock trading and investment forum Australia's #1 stock forum

SDX

Click for more information

0.00%

6.2¢ sienna cancer diagnostics limited

My view is sales and licensing to expand US market 2017 and move...

First 8 Last

Share
Profile

Follow
Bigsky

479 Posts.

20

11/08/17

00:09

Post #: 26430774
Share

Originally posted by beefarmer ↑

Bigsky, this was my second float this year and both have performed poorly. However saying that I would not have sold even if they performed like AL8.

I am a long termer, hence my serious like of CYC. In fact, CYC is my super stock but I wont bore you.

No one gives a cracker about the backroom fandangos if a miffed crowd are flogging the stock. Hopefully people can separate the wheat from the chaff and this little company has what it takes. For freddys sake, there is a nobel prize behind all this chemistry.

For those with cohunas, what better way than to top up at 15c, and make one third when she hits 20.

Make no mistake, she will hit 20. Again. Look at the other diagnostic testing that can be done here with other types of cancers. All it needs, like a lot of stocks, is that huge break and off we go.

Expand

My view is sales and licensing to expand US market 2017 and move into Europe 2017/18. R&D to commercialise other cancer diagnostics through 2020. Upside $100M market cap 2020 and happy days. I am holding and here for the ride. DYOR

SDX Price at posting: 15.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

HotCopper Highlights: Your most watched stocks for Week 48, 2024

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

There are more pages in this discussion • 1 more message in this thread...

First 8 Last

Add SDX (ASX) to my watchlist